Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses

• Kathryn L. Hopkins ,

  * E-mail: hopkinsk@PHRU.co.za

  Affiliation Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Fatima Laher,

  Affiliation Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Kennedy Otwombe,

  Affiliation Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Gavin Churchyard,

  Affiliation Aurum Institute for Health Research, Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Linda-Gail Bekker,

  Affiliation Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

  ⨯
• Stephen DeRosa,

  Affiliation HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Maphoshane Nchabeleng,

  Affiliation Medunsa HIV Clinical Research Unit, University of Limpopo, Pretoria, South Africa

  ⨯
• Koleka Mlisana,

  Affiliation Centre for AIDS Programme for Research in South Africa & Department of Medical Microbiology, University of KwaZulu-Natal, Durban, South Africa

  ⨯
• James Kublin,

  Affiliation HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Glenda Gray

  Affiliation Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯